You have 9 free searches left this month | for more free features.

Lifitegrast

Showing 1 - 25 of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dry Eye Trial in New York (Lifitegrast 5% Ophthalmic Solution, Lifitegrast Ophthalmic Solution Vehicle)

Not yet recruiting
  • Dry Eye
  • Lifitegrast 5% Ophthalmic Solution
  • Lifitegrast Ophthalmic Solution Vehicle
  • New York, New York
    State University of New York College of Optometry Clinical Visio
Aug 16, 2022

Patterns, Real-world Effectiveness, and Healthcare Resource

Not yet recruiting
  • Dry Eye Disease
  • lifitegrast
  • (no location specified)
May 10, 2023

Ocular Discomfort in Glaucoma Patients Using Multiple Topical

Recruiting
  • Glaucoma
  • Ocular Surface Disease
  • Xiidra (Lifitegrast ophthalmic solution) 5%
  • Fountain Valley, California
    Doheny Eye Center UCLA
Oct 31, 2022

Graft-versus-host-disease, Ocular Graft-versus-host Disease Trial in Bellaire (Lifitegrast 5% Ophthalmic Solution, Refresh)

Not yet recruiting
  • Graft-versus-host-disease
  • Ocular Graft-versus-host Disease
  • Lifitegrast 5% Ophthalmic Solution
  • Refresh
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Apr 27, 2022

Dry Eye Trial in Waterloo (Xiidra)

Recruiting
  • Dry Eye
  • Waterloo, Ontario, Canada
    Centre for Ocular Research & Education
Jan 26, 2023

Dry Eye Trial in Laguna Hills, Jacksonville, Brecksville (Lifitegrast 5% Ophthalmic Solution)

Completed
  • Dry Eye
  • Lifitegrast 5% Ophthalmic Solution
  • Laguna Hills, California
  • +2 more
Oct 8, 2021

Dry Eye Syndromes Trial in Kansas City (Lifitegrast Ophthalmic, Systane Free, Lipiflow)

Active, not recruiting
  • Dry Eye Syndromes
  • Lifitegrast Ophthalmic
  • +2 more
  • Kansas City, Missouri
    joseph Tauber
Oct 25, 2022

Dry Eye Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Xiidra® (5% lifitegrast ophthalmic solution))

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Xiidra® (5% lifitegrast ophthalmic solution)
  • Mississauga, Ontario, Canada
    Cliantha Research
Sep 26, 2022

Dry Eye Trial in Nashville (nanomicellular cyclosporine 0.09%, Lifitegrast)

Recruiting
  • Dry Eye
  • nanomicellular cyclosporine 0.09%
  • Lifitegrast
  • Nashville, Tennessee
    Toyos Clinic
Oct 4, 2021

Dry Eye, Dry Eye Syndromes, Dry Eyes Chronic Trial in New York (Lifitegrast 5% Ophthalmic Solution)

Withdrawn
  • Dry Eye
  • +2 more
  • Lifitegrast 5% Ophthalmic Solution
  • New York, New York
    Weill Cornell Ophthalmology
Feb 10, 2021

Corneal Disease Trial in Abu Dhabi (Xiidra 5% Ophthalmic Solution)

Recruiting
  • Corneal Disease
  • Xiidra 5% Ophthalmic Solution
  • Abu Dhabi, United Arab Emirates
    INMC
Sep 7, 2021

Dry Eye Trial in Wilkes-Barre (Lifitegrast 5% Ophthalmic Solution)

Enrolling by invitation
  • Dry Eye
  • Lifitegrast 5% Ophthalmic Solution
  • Wilkes-Barre, Pennsylvania
    Bucci Laser Vision
Sep 28, 2021

Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
  • Dry Eye Disease
  • Lifitegrast
  • Placebo
  • Artesia, California
  • +22 more
Jun 2, 2021

Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
  • Dry Eye Disease
  • Lifitegrast
  • Placebo
  • Artesia, California
  • +30 more
Jun 2, 2021

Allergic Conjunctivitis Trial in Andover (Lifitegrast, Placebo)

Completed
  • Allergic Conjunctivitis
  • Lifitegrast
  • Placebo
  • Andover, Massachusetts
    Ora
Jun 2, 2021

Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
  • Dry Eye Disease
  • Lifitegrast
  • Placebo
  • Birmingham, Alabama
  • +40 more
Jun 2, 2021

And Symptoms In Dry Eye Patients Undergoing Cataract Surgery

Completed
  • Dry Eye
  • Lifitegrast
  • Laguna Hills, California
    Harvard Eye Associates
Mar 18, 2020

Dry Eye Trial in United States (Lifitegrast, Placebo)

Completed
  • Dry Eye
  • Lifitegrast
  • Placebo
  • Waterbury, Connecticut
  • +4 more
Aug 5, 2021

Dry Eye Syndromes Trial in Miami (Self retained cryopreserved amniotic membrane, lifitegrast ophthalmic solution)

Terminated
  • Dry Eye Syndromes
  • Self retained cryopreserved amniotic membrane
  • lifitegrast ophthalmic solution
  • Miami, Florida
    Center of Excellence in Eye Care
Oct 5, 2020

Keratoconjunctivitis Sicca, Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
  • Keratoconjunctivitis Sicca
  • Dry Eye Disease
  • Lifitegrast
  • Placebo
  • Waterbury, Connecticut
  • +12 more
Jun 2, 2021

Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium

Completed
  • Dry Eye Disease
  • SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
  • +6 more
  • Phoenix, Arizona
  • +39 more
Apr 10, 2022

Dry Eye Trial in Guangzhou (CsA Ophthalmic Gel, Placebo, Hypromellose Eye Drop)

Completed
  • Dry Eye
  • CsA Ophthalmic Gel
  • +2 more
  • Guangzhou, Guangdong, China
    Ophthalmological Center of Zhongshan University
Apr 21, 2022

Ocular Discomfort, Ocular Inflammation, Dry Eye Trial (Lifitegrast)

Withdrawn
  • Ocular Discomfort
  • +4 more
  • Lifitegrast
  • (no location specified)
May 15, 2019

Contact Lens Dry Eye Trial in Birmingham (Lifitegrast)

Withdrawn
  • Contact Lens Dry Eye
  • Lifitegrast
  • Birmingham, Alabama
    University of Alabama at Birmingham
Oct 23, 2018

Contact Lens, Contact Lens Discomfort, Contact Lens Dryness Trial in Richardson (Lifitegrast)

Completed
  • Contact Lens
  • +2 more
  • Lifitegrast
  • Richardson, Texas
    Eye & Vision
Sep 26, 2018